You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

04-101

Showing 1 - 25 of 4,557
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluating the Safety of CS20AT04 in Lupus Nephritis

Active, not recruiting
  • Lupus Nephritis
    • Seoul, Korea, Republic of
      Hanyang university hospital
    Mar 8, 2022

    Atopic Dermatitis Trial in United States (TER-101, Vehicle)

    Completed
    Has Results
    • Atopic Dermatitis
    • Scottsdale, Arizona
    • +11 more
    Jul 19, 2022

    Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)

    Recruiting
    • Urothelial Carcinoma
    • Zilovertamab vedotin
    • Cleveland, Ohio
    • +11 more
    Jan 25, 2023

    Acne Vulgaris Trial in Dominican Republic, United States (FMX-101, 4% minocycline foam, Vehicle Foam)

    Completed
    Has Results
    • Acne Vulgaris
    • FMX-101, 4% minocycline foam
    • Vehicle Foam
    • Birmingham, Alabama
    • +30 more
    Jan 13, 2022

    Primary Sclerosing Cholangitis Trial in Germany, Israel, United Kingdom (CM-101, Placebo)

    Recruiting
    • Primary Sclerosing Cholangitis
    • CM-101
    • Placebo
    • Bonn, Germany
    • +20 more
    Sep 1, 2021

    Wilson Disease Trial in Worldwide (ALXN1840, Standard of Care)

    Recruiting
    • Wilson Disease
    • Parkville, Australia
    • +18 more
    Jun 3, 2022

    Migraine Trial in Worldwide (Lu AG09222, Placebo)

    Active, not recruiting
    • Migraine
    • Lu AG09222
    • Placebo
    • Oceanside, California
    • +27 more
    Dec 7, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +14 more
    • Biopsy
    • +25 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2022

    Lenalidomide With Tumor Flare Reaction and High Tumor Burden in

    Recruiting
    • Lymphoma, Mantle-Cell
    • Graz, Austria
    • +86 more
    Oct 19, 2022

    Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Trial in Worldwide (BAY1817080, Placebo for BAY1817080, Placebo

    Terminated
    • Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
    • Chocen, Czechia
    • +41 more
    Dec 8, 2022

    Solid Tumor Trial in China (BPB-101)

    Not yet recruiting
    • Solid Tumor
    • Guangzhou, Guangdong, China
    • +3 more
    May 11, 2023

    Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Adelaide, South Australia, Australia
      Research Site
    Apr 5, 2023

    Ulcerative Colitis Trial in Seoul (INV-101)

    Completed
    • Ulcerative Colitis
    • Seoul, Korea, Republic of
      Innovo Therapeutics, Inc.
    Apr 25, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Houston, Texas
      M D Anderson Cancer Centerl
    Apr 25, 2023

    Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 22, 2022

    Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

    Recruiting
    • Solid Tumor, Adult
    • +19 more
    • Irving, Texas
    • +2 more
    May 24, 2023

    QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)

    Recruiting
    • QT/QTc
    • Ecopipam Hydrochloride
    • +2 more
    • Austin, Texas
      PPD Austin Phase 1 Clinical Research Unit
    Apr 21, 2023

    Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

    Recruiting
    • Head and Neck Cancer
    • +2 more
    • Tucson, Arizona
    • +16 more
    Nov 15, 2022

    Erosive Esophagitis Trial in United States (BLI5100, PPI Control)

    Recruiting
    • Erosive Esophagitis
    • Huntsville, Alabama
    • +70 more
    Jan 23, 2023

    Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)

    Active, not recruiting
    • Atopic Dermatitis Eczema
    • ARQ-151 Active
    • ARQ-151 Vehicle
    • Montgomery, Alabama
    • +48 more
    Aug 10, 2022

    R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial (CNTY-101, IL-2,

    Recruiting
    • R/R CD19-Positive B-Cell Malignancies
    • +2 more
    • CNTY-101
    • +2 more
    • Detroit, Michigan
    • +1 more
    Dec 21, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

    Recruiting
    • Ovarian Cancer
    • +3 more
    • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
    • Blacktown, New South Wales, Australia
    • +5 more
    Nov 9, 2022

    Normal Tension Glaucoma Trial in Sioux Falls (QLS-101)

    Completed
    • Normal Tension Glaucoma
    • Sioux Falls, South Dakota
      Vance Thompson Vision
    Oct 7, 2022

    Endogenous Cushing's Syndrome Trial in Worldwide (Levoketoconazole, Placebo)

    Completed
    Has Results
    • Endogenous Cushing's Syndrome
    • Los Angeles, California
    • +44 more
    Oct 13, 2022

    Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Fairway, Houston (SC291)

    Recruiting
    • Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Fairway, Kansas
    • +1 more
    May 30, 2023